m
Recent Posts
Connect with:
Wednesday / October 28.
HomeminewsGlaucoma and Corneal Cross Linking Webinar

Glaucoma and Corneal Cross Linking Webinar

A two part webinar on optometry’s role in glaucoma management and corneal cross linking will be presented live online on 15 September 2020, from 7pm to 8pm.

Hosted by Glaukos, the webinar will be presented by optometrist Jason Holland, who runs a dedicated glaucoma and advanced dry eye clinic in Brisbane.

Session One: Micro Bypass Glaucoma Surgery 

Glaucoma is incurable, however early intervention can delay or stop the progression of the disease. Treatment is focused on lowering intraocular pressure (IOP) and typically begins with eye drops. Glaucoma medications are a burden to patients and can have side effects on the ocular surface and lead to non-compliance.

Mr Holland will discuss ocular surface disease as a result of glaucoma medications and early interventions, including micro bypass glaucoma surgery, that are available to lower IOP, reduce medication burden and improve ocular surface health.

Session Two: Corneal Cross Linking 

Keratoconus (KC), is a noninflammatory eye condition in which the cornea progressively thins and weakens, causing the development of a cone-like bulge and irregular astigmatism. KC can result in significant vision loss and, in severe cases, can lead to corneal transplantation.

Mr Holland will discuss the safety and effectiveness of corneal crosslinking and the benefits of early diagnosis and intervention with corneal crosslinking to preserve a patient’s vision and quality of life.

Register at: glaukos.zoom. us/webinar/register/WN_ enhkDLV4TdqUOD_YfCVThQ. CPD points have been applied for.

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.